Relationship between differentiation mechanisms involving cAMP-dependent protein kinase and protein kinase C in uninduced and differentiating HL-60 cells

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 285-292

  Savickiene, Jurate ^a   Gineitis, Arunas ^a   Shanbhag, Vithaldas P ^b   Stigbrand, Torgny ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Differentiation; HL 60 cells; Protein kinases inhibition

Indexed keywords

BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; RETINOIC ACID; STAUROSPORINE;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GRANULOCYTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

BUCLADESINE; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HL-60 CELLS; HUMANS; PROTEIN KINASE C; STAUROSPORINE; TRETINOIN;

EID: 0031056988     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Collins S: The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogen expression. Blood 70: 1233-1244, 1487.
2. Fontana J A, Emler C, Ku K, McClung J K, Butcher F R and Durham L: Cyclic AMP-dependent and -independent protein kinases and protein phosphorylation in human promyelocytic leukemia (HL-60) cells induced to differentiate. J Cell Physiol 120: 49-60, 1984.
3. Fontana J, Miksis G and Durham J: Elevation of adenylate cyclase activity during leukemic cell differentiation. Exptl Cell Res 168: 487-493, 1987.
4. Nomika T, Mio M, Doi M and Tasaka K: Histamine-induced differentiation of HL-60 cells. The role of cAMP and protein kinase A. Biochem Pharmacol 44: 1115-1121, 1992.
5. Kiss Z, Deli E and Kuo JF: Temporal changes in intracellular distribution of protein kinase C during differentiation of human leukemia HL-60 cells induced by phorbol ester. FEBS Letters 231: 41-46, 1988.
6. Hashimoto K, Kishimoto A, Aihara H, Yasuda I, Mikawa K and Nishizuka Y: Protein kinase C during differentiation of human promyelocytic leukemia cell line. HL-60. FEBS Letters 263: 31-34, 1990.
7. Aihara H, Asaoka Y, Yoshida and Nishizuka Y: Sustained activation of protein kinase C is essential to HL-60 cell differentiation to macrophage. Proc Natl Acad Sci USA 88: 11062-11066, 1991.
8. Okuda T, Sawada H, Kato Y, Yumoto Y, Ogawa K, Tashima M and Okuma M: Effects of protein kinase A and calcium/phospholipid-dependent kinase modulators in the process of HL-60 cell differentiation: their opposite effects between HL-60 cell and K-562 cell differentiation. Cell Growt and Differ 2: 415-420, 1991.
9. Hardy S J, Haylock D N, Lopez A F and Murray A W: Examination of the role of the proteolytically-activated form of protein kinase C in the differentiation of human haemopoietic cells. Differentiation 50: 189-202, 1992.
10. Hui E K-W and Yung B Y-M: Protein kinase C activity during sphinganine potentiation of retinoic acid-induced differentiation in a human leukemia cell line (HL-60). Life Sci 51: 415-422, 1992.
11. Tanaka Y, Yoshihara K, Tsuyuki M, Itaya-Hironaka A, Inada Y and Kamiya T: Retinoic acid-specific induction of a protein kinase C isoform during differentiation of HL-60 cell. J Biochem 111: 265-271, 1992.
12. Rohlff C, Clair T and Cho-Chung YS: 8-Cl-cAMP induces truncation and down regulation of the Ria subunit and up-regulation of the RIIβ subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J Biol Chem 268:5774-5782, 1993.
13. Yung B Y-M, Hsiao T-F, Wei L L-L and Hui E K-W: Sphinganine potentiation of dimethyl sulfoxide-induced granulocytic differentiation, increase of alkaline phosphatase activity and decrease of protein kinase C activity in a human leukemia cell line (HL-60). Biochem Biophys Res Commun 199: 888-896, 1994.
14. Kharbanda S, Saleen A, Emoto Y, Stone R, Rapp U and Kufe D: Activation of Raf-1 and mitogen activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J Biol Chem 269: 872-8 78, 1994.
15. Macfarlane D E and Manzel L: Activation of β-isozyme of protein kinase C (PKCβ) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. J Biol Chem 269: 4327-4331, 1994.
16. Savickiene J, Gineitis A, Shanbhag V P and Stigbrand T: Protein kinase inhibitors exert stage specific and inducer dependent effects on HL-60 cell differentiation. Anticancer Res 15: 687-692, 1995.
17. Collins SJ, Gallo RC and Gallagher RE: Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature: 270: 347-349, 1977.
18. Karin M and Hunter T: Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Current Biol: 5: 747-757, 1995.
19. Traverse S, Seedorf K, Paterson H, Marshall JC, Cohen P and Ullrich A: EGF triggers neuronal differentiation of PC 12 cells that overexpress the EFG receptor. Current Biol 4: 694-701, 1994.
20. Dikic I, Schlesinger J and Lax I: PC 12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Current Biol 4: 702-708, 1994.
21. Kurie JM, Younes A, Miller WH Jr, Burchet M, Chiu C-F, Kolesnik R and Dimitrovsky E: Retinoic acid stimulates the protein kinase C pathway before activation of its β-nuclear receptor during human teratocarcinoma differentiation. Biochim Biophys Acta 1179: 203-207, 1993.
22. Olsson IL, Breitman TR and Gallo RC: Priming of human leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3′: 5′-cyclic monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. Cancer Res 42: 3928-3933, 1982.
23. Chaplinski TJ and Neidl JE: Cyclic nucleotide-induced maturation of human promyelocytic leukemia cells. J. Clin Invest 70: 953-964, 1982.
24. Hikada H, Inagaki M, Kawamoto S an Sasaki Y: Isoquinoline-sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036-5041, 1984.
25. Ward N E and O Brian C A: Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates. Mol Pharmacol 41: 387-392, 1992.
26. Ido M, Naguo Y, Higashigawa M, Shibata T, Taniguchi K, Hamazaki M and Sakurai M: Differential growth inhibition of isoquinoline-sulfonamides H8 and H7 towards multidrug-resistant P3S8 murine leukemia cells. Br J Cancer 64: 1103-1107, 1991
27. Laredo J, Demur C, Muller C, Saivin S, Cassar G, Bousquet C, Dastuge N, Jaffrezau JP, Colombies P and Laurent G: Effects of H-7 and staurosporine on proliferation and self-renewal of acute myeloid leukemia progenitors. Leukemia 7: 813-820, 1993.
28. Choi EJ, Xia Z, Villacrs EC and Storm D: The regulatory diversity of the mammalian adenylyl cyclases. Curr Opin Cell Biol 5: 269-273, 1993.
29. Green S: Promiscuous liaisons. Nature 361: 590-591, 1993.
30. Hug H and Sarre T: Protein kinase C isoenzymes: divergence in signal transduction. Biochem J 291: 329-343, 1993.
31. Houslay MD. "Crosstalk": a pivotal role for protein kinase C in modulating relationship between transduction pathways. Europ J Biochem 195: 9-27, 1991.
32. Makowske M, Ballester R, Cayre Y and Rosen OM: Immunochemical evidence that three protein kinase C isozymes increase in abundance during HL60 differentiation induced by dimethyl sulfoxide and retinoic acid. J Biol Chem 263: 3402-3410, 1988.
33. Torota G, Yokozaky H, Pepe S, Clair T and Cho-Chung Y S: Differentiation of HL-60 leukemia by type regulatory subunit antisence oligo deoxynucleotide of cAMP-dependent protein kinase. Proc Natl Acad Sci USA 88: 2011-2015, 1991.
34. Elias L and Stewart T: Subcellular distribution of cyclic adenosine 3′:5′-monophosphate-dependent protein kinase during the chemically induced differentiation of HL-60 cells. Cancer Res 44: 3075-3080, 1984.
35. Hocevar BA and Fields AP: Selective translocation of bII-protein kinase C to the nucleus of human promyelocytic (HL-60) leukemia cells. J Biol Chem 266: 28-33, 1991.
36. Kikawa U and Nishizuka Y: The role of protein kinase C in transmembrane signalling. Annu Rev Cell Biol 2: 14-78, 1986.
37. Cook SJ and McCormic F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069-1072, 1993.